Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Isis antisense compound and analogues covered by U.S. patent

Oct. 18, 1996

Targeted Genetics receives grant for its HER-2/neu oncogene inhibitor

Oct. 18, 1996

Natural antitumor indanone reported by Sagami

Oct. 18, 1996

Eisai claims RXR agonists

Oct. 18, 1996

New antitumor agents from Sagami

Oct. 18, 1996

VCAM-1 inhibitors from Sagami

Oct. 18, 1996

Banyu reports natural antitumor agent

Oct. 18, 1996

Tyrosine kinase inhibitor developed by Cephalon and TAP enters clinical trials

Oct. 18, 1996

Broader role of VEGF in tumor growth proposed

Oct. 18, 1996

Chemokine/cytokine combination effective for tumor therapy

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...